Rakuten Medical is a global oncology-focused biotechnology company developing precision, cell-targeting cancer therapies based on its Alluminox™ technology. The company is advancing investigational photoimmunotherapy to selectively kill cancer cells and induce tumor necrosis, with a mission to conquer cancer and improve outcomes for patients worldwide. Its activities span multiple regions including the United States, Japan, and Taiwan, and it emphasizes developing new standard-of-care cancer treatments through ongoing research, clinical programs, and collaborations.